<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39402787</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-4141</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>European journal of immunology</Title><ISOAbbreviation>Eur J Immunol</ISOAbbreviation></Journal><ArticleTitle>Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19.</ArticleTitle><Pagination><StartPage>e2451236</StartPage><MedlinePgn>e2451236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eji.202451236</ELocationID><Abstract><AbstractText>Messenger RNA (mRNA) vaccines represent a new class of vaccines that has been shown to be highly effective during the COVID-19 pandemic and that holds great potential for other preventative and therapeutic applications. While it is known that the transcriptional activity of various genes is altered following mRNA vaccination, identifying and studying gene networks could reveal important scientific insights that might inform future vaccine designs. In this study, we conducted an in-depth weighted gene correlation network analysis of the blood transcriptome before and 24 h after the second and third vaccination with licensed mRNA vaccines against COVID-19 in humans, following a prime vaccination with either mRNA or ChAdOx1 vaccines. Utilizing this unsupervised gene network analysis approach, we identified distinct modular networks of co-varying genes characterized by either an expressional up- or downregulation in response to vaccination. Downregulated networks were associated with cell metabolic processes and regulation of transcription factors, while upregulated networks were associated with myeloid differentiation, antigen presentation, and antiviral, interferon-driven pathways. Within this interferon-associated network, we identified highly connected hub genes such as STAT2 and RIGI and associated upstream transcription factors, potentially playing important regulatory roles in the vaccine-induced immune response. The expression profile of this network significantly correlated with S1-specific IgG levels at the follow-up visit in vaccinated individuals. Those findings could be corroborated in a second, independent cohort of mRNA vaccine recipients. Collectively, results from this modular gene network analysis enhance the understanding of mRNA vaccines from a systems immunology perspective. Influencing specific gene networks could lead to optimized vaccines that elicit augmented vaccine responses.</AbstractText><CopyrightInformation>© 2024 The Author(s). European Journal of Immunology published by Wiley‐VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riemann</LastName><ForeName>Lennart</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weskamm</LastName><ForeName>Leonie M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-1175-7354</Identifier><AffiliationInfo><Affiliation>Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odak</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0408-5091</Identifier><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammerschmidt</LastName><ForeName>Swantje</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0718-0422</Identifier><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandrock</LastName><ForeName>Inga</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedrichsen</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravens</LastName><ForeName>Inga</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuss</LastName><ForeName>Janina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Gesine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Paediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center of Lung Research (DZL), BREATH, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addo</LastName><ForeName>Marylyn M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Förster</LastName><ForeName>Reinhold</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, 20246, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center of Lung Research (DZL), BREATH, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, partner site Braunschweig-Hannover, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>project 407495230</GrantID><Agency>Research Infrastructure NGS</Agency><Country /></Grant><Grant><GrantID>Project ID39087428</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country /></Grant><Grant><GrantID>SFB 900/3</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country /></Grant><Grant><GrantID>Project B1 158989968</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country /></Grant><Grant><GrantID>FO334/7-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country /></Grant><Grant><GrantID>project 423957469</GrantID><Agency>Generation Sequencing Competence Network</Agency><Country /></Grant><Grant><GrantID>TTU01.938</GrantID><Agency>German Centre for Infection Research (DZIF)</Agency><Country /></Grant><Grant><GrantID>TTU01.702</GrantID><Agency>German Centre for Infection Research (DZIF)</Agency><Country /></Grant><Grant><GrantID>TTU01.709</GrantID><Agency>German Centre for Infection Research (DZIF)</Agency><Country /></Grant><Grant><GrantID>82DZL002B1</GrantID><Agency>German Centre for Lung Research</Agency><Country /></Grant><Grant><Agency>Else Kröner-Fresenius Stiftung (Fördervertrag 2018_Kolleg.12)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Immunol</MedlineTA><NlmUniqueID>1273201</NlmUniqueID><ISSNLinking>0014-2980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BNT162b2</Keyword><Keyword MajorTopicYN="N">Gene networks</Keyword><Keyword MajorTopicYN="N">Systems vaccinology</Keyword><Keyword MajorTopicYN="N">Vaccine response</Keyword><Keyword MajorTopicYN="N">mRNA vaccines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402787</ArticleId><ArticleId IdType="doi">10.1002/eji.202451236</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Rodrigues, C. M. C. and Plotkin, S. A. Impact of vaccines; health, economic and social perspectives. Front Microbiol 2020. 11. https://www.frontiersin.org/articles/10.3389/fmicb.2020.01526</Citation></Reference><Reference><Citation>Pollard, A. J. and Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 2021. 21: 83–100.</Citation></Reference><Reference><Citation>Rzymski, P., Szuster‐Ciesielska, A., Dzieciątkowski, T., Gwenzi, W. and Fal, A. mRNA vaccines: the future of prevention of viral infections? J Med Virol 2023. 95: e28572.</Citation></Reference><Reference><Citation>Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D. et al., Efficacy and safety of the mRNA‐1273 SARS‐CoV‐2 vaccine. New Eng J Med 2020. 384: 403–416.</Citation></Reference><Reference><Citation>Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L. et al., Safety and efficacy of the BNT162b2 mRNA Covid‐19 vaccine. New Eng J Med 2020. 383: 2603–2615.</Citation></Reference><Reference><Citation>Wang, K., Wang, L., Li, M., Xie, B., He, L., Wang, M., Zhang, R. et al., Real‐word effectiveness of global COVID‐19 vaccines against SARS‐CoV‐2 variants: a systematic review and meta‐analysis. Front Med (Lausanne) 2022. 9. https://www.frontiersin.org/articles/10.3389/fmed.2022.820544</Citation></Reference><Reference><Citation>Zheng, C., Shao, W., Chen, X., Zhang, B., Wang, G. and Zhang, W. Real‐world effectiveness of COVID‐19 vaccines: a literature review and meta‐analysis. Int J Infect Dis 2022. 114: 252–260.</Citation></Reference><Reference><Citation>Rosenblum, H. G., Gee, J., Liu, R., Marquez, P. L., Zhang, B., Strid, P., Abara, W. E. et al., Safety of mRNA vaccines administered during the initial 6 months of the US COVID‐19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v‐safe. Lancet Infect Dis 2022. 22: 802–812.</Citation></Reference><Reference><Citation>Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P. and Ghani, A. C. Global impact of the first year of COVID‐19 vaccination: a mathematical modelling study. Lancet Infect Dis 2022. 22: 1293–1302.</Citation></Reference><Reference><Citation>Deng, Z., Tian, Y., Song, J., An, G. and Vaccines, Y. P. mRNA: the dawn of a new era of cancer immunotherapy. Front Immunol 2022. 13. https://www.frontiersin.org/articles/10.3389/fimmu.2022.887125</Citation></Reference><Reference><Citation>Arunachalam, P. S., Scott, M. K. D., Hagan, T., Li, C., Feng, Y., Wimmers, F., Grigoryan, L. et al., Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 2021. 596: 410–416.</Citation></Reference><Reference><Citation>Ryan, F. J., Norton, T. S., McCafferty, C., Blake, S. J., Stevens, N. E., James, J., Eden, G. L. et al., A systems immunology study comparing innate and adaptive immune responses in adults to COVID‐19 mRNA and adenovirus vectored vaccines. Cell Rep Med 2023. 4: 100971.</Citation></Reference><Reference><Citation>Takano, T., Morikawa, M., Adachi, Y., Kabasawa, K., Sax, N., Moriyama, S., Sun, L. et al., Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS‐CoV‐2 mRNA vaccine. Cell Rep Med 2022. 3: 100631.</Citation></Reference><Reference><Citation>Bošnjak, B., Stein, S. C., Willenzon, S., Cordes, A. K., Puppe, W., Bernhardt, G., Ravens, I. et al., Low serum neutralizing anti‐SARS‐CoV‐2 S antibody levels in mildly affected COVID‐19 convalescent patients revealed by two different detection methods. Cell Mol Immunol 2021. 18: 936–944.</Citation></Reference><Reference><Citation>Odak, I., Riemann, L., Sandrock, I., Cossmann, A., Ramos, G. M., Hammerschmidt, S. I., Ritter, C. et al., Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID‐19 vaccine. EBioMedicine 2024. 99.</Citation></Reference><Reference><Citation>Bray, N. L., Pimentel, H., Melsted, P. and Pachter, L. Near‐optimal probabilistic RNA‐seq quantification. Nat Biotechnol 2016. 34: 525–527.</Citation></Reference><Reference><Citation>Zhang, Y., Parmigiani, G. and Johnson, W E. ComBat‐seq: batch effect adjustment for RNA‐seq count data. NAR Genom Bioinform 2020; 2: lqaa078.</Citation></Reference><Reference><Citation>Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S., De Moor, B., Brazma, A. and Huber, W. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 2005. 21: 3439–3440.</Citation></Reference><Reference><Citation>Robinson, M. D., McCarthy, D. J. and Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010. 26: 139–140.</Citation></Reference><Reference><Citation>Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W. and Smyth, G. K. limma powers differential expression analyses for RNA‐sequencing and microarray studies. Nucleic Acids Res 2015. 43: e47–e47.</Citation></Reference><Reference><Citation>Keenan, A. B., Torre, D., Lachmann, A., Leong, A. K., Wojciechowicz, M. L., Utti, V., Jagodnik, K. M. et al., ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res 2019. 47: W212–W224.</Citation></Reference><Reference><Citation>Langfelder, P. and Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 2008. 9: 559.</Citation></Reference><Reference><Citation>Love, M. I., Huber, W. and Anders, S. Moderated estimation of fold change and dispersion for RNA‐seq data with DESeq2. Genome Biol. 2014; 15: 550.</Citation></Reference><Reference><Citation>Horvath, S. and Dong, J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 2008. 4: e1000117.</Citation></Reference><Reference><Citation>Yu, G., Wang, L. G., Han, Y. and He, Q. Y. clusterProfiler: an R Package for comparing biological themes among gene clusters OMICS. 2012. 16: 284–287.</Citation></Reference><Reference><Citation>Feikin, D. R., Higdon, M. M., Abu‐Raddad, L. J., Andrews, N., Araos, R., Goldberg, Y., Groome, M. J. et al., Duration of effectiveness of vaccines against SARS‐CoV‐2 infection and COVID‐19 disease: results of a systematic review and meta‐regression. The Lancet 2022. 399: 924–944.</Citation></Reference><Reference><Citation>Collier, D. A., Ferreira, I., Kotagiri, P., Datir, R. P., Lim, E. Y., Touizer, E., Meng, B. et al., Age‐related immune response heterogeneity to SARS‐CoV‐2 vaccine BNT162b2. Nature 2021. 596: 417–422.</Citation></Reference><Reference><Citation>Barros‐Martins, J., Hammerschmidt, S. I., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Dopfer‐Jablonka, A. et al., Immune responses against SARS‐CoV‐2 variants after heterologous and homologous ChAdOx1 nCoV‐19/BNT162b2 vaccination. Nat Med 2021. 27: 1525–1529.</Citation></Reference><Reference><Citation>Wang, Y., Schughart, K., Pelaia, T. M., Chew, T., Kim, K., Karvunidis, T., Knippenberg, B. et al., Blood transcriptome responses in patients correlate with severity of COVID‐19 disease. Front Immonol 2023. 13.</Citation></Reference><Reference><Citation>Bernardes, J. P., Mishra, N., Tran, F., Bahmer, T., Best, L., Blase, J. I., Bordoni, D. et al., Longitudinal multi‐omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID‐19. Immunity 2020. 53: 1296–1314.</Citation></Reference><Reference><Citation>Voigt, E. A., Grill, D. E., Zimmermann, M. T., Simon, W. L., Ovsyannikova, I. G., Kennedy, R. B. and Poland, G. A. Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data‐driven clustering. Sci Rep 2018; 8: 739.</Citation></Reference><Reference><Citation>Li, C., Lee, A., Grigoryan, L., Arunachalam, P. S., Scott, M. K. D., Trisal, M., Wimmers, F. et al., Mechanisms of innate and adaptive immunity to the Pfizer‐BioNTech BNT162b2 vaccine. Nat Immunol 2022. 23: 543–555.</Citation></Reference><Reference><Citation>He, Y., Sun, M., Xu, Y., Hu, C., Wang, Y., Zhang, Y., Fang, J. et al., Weighted gene co‐expression network‐based identification of genetic effect of mRNA vaccination and previous infection on SARS‐CoV‐2 infection. Cell Immunol 2023. 385: 104689.</Citation></Reference><Reference><Citation>Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie‐Kunze, S., Haining, W. N., Means, A. R. et al., Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011. 12: 786–795.</Citation></Reference><Reference><Citation>Bucasas, K. L., Franco, L. M., Shaw, C. A., Bray, M. S., Wells, J. M., Niño, D., Arden, N. et al., Early Patterns of Gene Expression Correlate With the Humoral Immune Response to Influenza Vaccination in Humans. J Infect Dis 2011. 203: 921–929.</Citation></Reference><Reference><Citation>Kim, E. Y., Che, Y., Dean, H. J., Lorenzo‐Redondo, R., Stewart, M., Keller, C. K., Whorf, D. et al., Transcriptome‐wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine. Cell Rep 2022. 38: 110341.</Citation></Reference><Reference><Citation>Niu, X., Zhang, J., Zhang, L., Hou, Y., Pu, S., Chu, A., Bai, M. et al., Weighted gene co‐expression network analysis identifies critical genes in the development of heart failure after acute myocardial infarction. Front Genet. 2019. 10. https://www.frontiersin.org/articles/10.3389/fgene.2019.01214</Citation></Reference><Reference><Citation>Zhu, Y., Tang, Y., Peng, Y., Hu, P., Sun, W., Jin, M., Liu, P. et al., Identification of hub gene and transcription factor related to chronic allograft nephropathy based on WGCNA analysis. Kidney Blood Press Res. 2022. 47: 631–642.</Citation></Reference><Reference><Citation>Yuan, L., Chen, L., Qian, K., Qian, G., Wu, C. L., Wang, X. and Xiao, Y. Co‐expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Genom Data. 2017. 14: 132–140.</Citation></Reference><Reference><Citation>Horvath, S., Zhang, B., Carlson, M., Lu, K. V., Zhu, S., Felciano, R. M., Laurance, M. F. et al., Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proceed Nat Acad Sci. 2006. 103: 17402–17407.</Citation></Reference><Reference><Citation>Steen, H. C. and Gamero, A. M. The role of signal transducer and activator of transcription‐2 in the interferon response. J Interferon Cytokine Res. 2012. 32: 103–110.</Citation></Reference><Reference><Citation>Rehwinkel, J. and Gack, M. U. RIG‐I‐like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 2020. 20: 537–551.</Citation></Reference><Reference><Citation>Kulkarni, R. R., Rasheed, M. A. U., Bhaumik, S. K., Ranjan, P., Cao, W., Davis, C., Marisetti, K. et al., Activation of the RIG‐I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose‐sparing effect and protective immunity. 2014. 88.</Citation></Reference><Reference><Citation>Chen, Y., Song, W., Li, C., Wang, J., Liu, F., Ye, Z., Ren, P. et al., COVID‐19 mRNA vaccine protects against SARS‐CoV‐2 Omicron BA.1 infection in diet‐induced obese mice through boosting host innate antiviral responses. EBioMedicine 2023. 89.</Citation></Reference><Reference><Citation>Rinchai, D., Deola, S., Zoppoli, G., Kabeer, B. S. A., Taleb, S., Pavlovski, I., Maacha, S. et al., High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID‐19 mRNA vaccines. Sci Adv 2024. 8: eabp9961.</Citation></Reference><Reference><Citation>Lee, J., Woodruff, M. C., Kim, E. H. and Nam, J. H. Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines. Exp Mol Med 2023.</Citation></Reference><Reference><Citation>Ciabattini, A., Nardini, C., Santoro, F., Garagnani, P., Franceschi, C. and Medaglini, D. Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol. 2018. 40: 83–94.</Citation></Reference><Reference><Citation>Bai, J., Chiba, A., Murayama, G., Kuga, T., Tamura, N. and Sex, M. S., Age, and ethnic background shape adaptive immune responses induced by the SARS‐CoV‐2 mRNA Vaccine. Front Immunol 2022. 13. Available at: https://www.frontiersin.org/articles/10.3389/fimmu.2022.786586</Citation></Reference><Reference><Citation>Korosec, C. S., Farhang‐Sardroodi, S., Dick, D. W., Gholami, S., Ghaemi, M. S., Moyles, I. R., Craig, M. et al., Long‐term durability of immune responses to the BNT162b2 and mRNA‐1273 vaccines based on dosage, age and sex. Sci Rep 2022. 12: 21232.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>